Global Automated Breast Ultrasound Systems (ABUS) Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Automated Breast Ultrasound Systems (ABUS) market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Automated Breast Ultrasound Systems (ABUS) market."
ABUS is a comfortable, non-ionizing alternative to other supplemental screening options for women with dense breast tissue. 
Approximately 40% of American women have dense breasts.Having dense breasts can increase a womans risk to develop cancer by 4-6 times.Mammography may miss cancers in dense breasts, Invenia ABUS has been proven to find 55% more invasive cancers after a normal or benign mammographic finding.

The global Automated Breast Ultrasound Systems (ABUS) market is valued at 590 million US$ in 2018 is expected to reach 1930 million US$ by the end of 2025, growing at a CAGR of 16.0% during 2019-2025.
This report focuses on Automated Breast Ultrasound Systems (ABUS) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Automated Breast Ultrasound Systems (ABUS) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    GE Healthcare
    Hitachi
    Koninklijke Philips N.V.
    Siemens
    SonoCine
    QView Medical
    Seno Medical Instruments
    Volpara Solutions
    Delphinus Medical Technologies
    CapeRay
    SuperSonic Imagine
    Nova Medical Imaging TechnologyLtd.
    Shantou Institute of Ultrasonic Instruments (SIUI)
    Theraclion
    Real Imaging
    MetriTrack
    Toshiba Company

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Automated Breast Ultrasound Systems(ABUS)
    Automated Breast Volume Scanner (ABVS)

Segment by Application
    Hosptials
    Diagnostic Imaging Centers